Polymerase chain reaction-based methods for the detection of mutations in oncogenes and tumor suppressor genes

M Loda1

  • 1Deaconess Hospital, Department of Pathology, Boston, MA 02215.

Human Pathology
|June 1, 1994
PubMed

Insights

Polymerase chain reaction (PCR) enhances mutation detection sensitivity, aiding cancer research and diagnosis. These PCR-based methods are crucial for understanding cancer development and classifying malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Altered oncogene and tumor suppressor gene expression is key in cancer development.
  • Mutations in these genes often lead to aberrant expression and uncontrolled cell growth.
  • Detecting these genetic alterations is vital for understanding carcinogenesis.

Purpose of the Study:

  • To outline PCR-based strategies for mutation detection.
  • To discuss the applicability of these techniques for various mutation types.
  • To present the use of PCR in analyzing fresh and archival tissues.

Main Methods:

  • Utilizing polymerase chain reaction (PCR) for in vitro DNA amplification.
  • Employing PCR-based techniques to increase mutation detection sensitivity.
  • Applying these methods to fresh and archival tissue samples.

Main Results:

  • PCR significantly enhances the sensitivity of mutation detection methods.
  • PCR-based strategies are effective in identifying diverse mutation types.
  • These techniques are applicable to both fresh and archival tissue specimens.

Conclusions:

  • PCR-based methods are invaluable for elucidating carcinogenesis mechanisms.
  • Mutation detection via PCR aids in cancer diagnosis, classification, and prognosis.
  • The application of PCR techniques in tissue analysis is broadly beneficial.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
PCR - Polymerase Chain Reaction01:32

PCR - Polymerase Chain Reaction

Overview
Real Time RT-PCR02:57

Real Time RT-PCR

Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...